See also this year's filing and all EDGAR filings for this company.
PDF Report 0001582313_2016_Xenon_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001582313, Xenon Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 60,866,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,989,000 |
| 3 | remainder_Assets | 1,094,000 |
| 4 | LiabilitiesCurrent | 2,782,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 133,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,786,000 |
| 9 | ResearchAndDevelopmentExpense | 15,152,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 15,577,000 |
| 12 | remainder_NetIncome | -6,391,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,949,000 |
| 1 | Liabilities | 2,915,000 |
| 2 | Expenses | 24,938,000 |
| 3 | Revenues | 15,577,000 |
| 4 | StockholdersEquity | 61,034,000 |
| 5 | NetIncome | -15,752,000 |
| 6 | ComprehensiveNetIncome | -15,752,000 |
| 7 | BaseVar | 56,885,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.51 |
| 9 | EconomicCapitalRatio | 4.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
